The effect of Turmeric on blood Indicators and blood pressure in hyperlipidemic type 2 diabetes mellitus patients

Phase 2

Conditions: hyperlipidemic type 2 diabetes mellitus patients.
Diabetes mellitus
E11,E12,E1

Registration Number: IRCT201204162602N7

Lead Sponsor: Tehran university of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 80

Inclusion Criteria

Willingness to participate in the study; People with type 2 diabetes; Aged people with 30 to 70 years of age; Aged people with 30 to 70 years of age; People having HbA1c above 6; Patients with TG>150mg/dl, LDL above 100mg/dl; Lack of consumption of multivitamin; supplements, antioxidants, polyphenols, since last three months;
BMI 20 – 35 .
Exclusion criteria of the study: Participants of the study under treatment had no changes in consumption of medicine; Patients having fasting blood glucose >200mg/dl or LDL>160mg/dl were excluded from the study; Changes in dose and type of medication;
Inclusion criteria for the study: Acute cardiac disease, renal failure, liver and thyroid disease; Rejection of turmeric powder supplement.
actation or pregnancy; Severe gastrointestinal disease and gastric ulcers; Risk of gall stones Changes in physical activity and diet;

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Systolic blood pressure. Timepoint: 8 weeks. Method of measurement: sphygmomanometer.;Diastolic blood pressure. Timepoint: 8 weeks. Method of measurement: sphygmomanometer.;FBS. Timepoint: 8 week. Method of measurement: Laboratory kit.;Fasting Insulin. Timepoint: 8 week. Method of measurement: Laboratory kit.;HbA1C. Timepoint: 8 weeks. Method of measurement: Laboratory kit.;Triglyceride (TG). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;Total Cholesterol (TC). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;LDL. Timepoint: 8 weeks. Method of measurement: Laboratory Kit.;HDL. Timepoint: 8 weeks. Method of measurement: Laboratory Kit.;Apo A-I. Timepoint: 8 weeks. Method of measurement: Laboratory Kit.;Apo B-100. Timepoint: 8 weeks. Method of measurement: Laboratory kit.;CRP. Timepoint: 8 weeks. Method of measurement: Laboratory kit.;TAC. Timepoint: 8 weeks. Method of measurement: Laboratory kit.

Secondary Outcome Measures